Articles with "2022 update" as a keyword



Photo from wikipedia

Chronic neutrophilic leukemia: 2022 update on diagnosis, genomic landscape, prognosis, and management

Sign Up to like & get
recommendations!
Published in 2022 at "American Journal of Hematology"

DOI: 10.1002/ajh.26481

Abstract: Chronic neutrophilic leukemia (CNL) is a rare, often aggressive myeloproliferative neoplasm (MPN) defined by persistent mature neutrophilic leukocytosis, bone marrow granulocyte hyperplasia, and frequent hepatosplenomegaly. The 2013 seminal discovery of oncogenic driver mutations in colony‐stimulating… read more here.

Keywords: leukemia 2022; chronic neutrophilic; neutrophilic leukemia; 2022 update ... See more keywords
Photo by nci from unsplash

2022 update on the scientific premise and clinical trials for IL‐15 agonists as cancer immunotherapy

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Leukocyte Biology"

DOI: 10.1002/jlb.5mr0422-506r

Abstract: Diverse cytokines and their receptors on immune cells constitute a highly complex network in the immune system. Some therapeutic cytokines and their derivatives have been approved for cancer treatment. IL‐15 is an immune‐regulating cytokine with… read more here.

Keywords: 2022 update; agonists cancer; cancer immunotherapy; cancer ... See more keywords
Photo from wikipedia

2022 Update of BCLC Treatment Algorithm of HCC: What’s New for Interventional Radiologists?

Sign Up to like & get
recommendations!
Published in 2022 at "CardioVascular and Interventional Radiology"

DOI: 10.1007/s00270-021-03047-1

Abstract: The Barcelona Clinic Liver Cancer (BCLC) system, initially proposed in 1999, is certainly the most commonly used staging system for HCC in Western countries. Just a few days ago, the BCLC group released the 2022… read more here.

Keywords: tace; treatment; bclc; 2022 update ... See more keywords
Photo from wikipedia

Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis

Sign Up to like & get
recommendations!
Published in 2022 at "Annals of the Rheumatic Diseases"

DOI: 10.1136/ard-2022-223365

Abstract: Objectives To update the evidence on efficacy of DMARDs (disease-modifying antirheumatic drugs) and inform the taskforce of the 2022 update of the European Alliance of Associations for Rheumatology (EULAR) recommendations for management of rheumatoid arthritis… read more here.

Keywords: 2022 update; review; eular recommendations; efficacy ... See more keywords
Photo by mikehindle from unsplash

Response to: Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update" by Ramiro et al

Sign Up to like & get
recommendations!
Published in 2023 at "Annals of the Rheumatic Diseases"

DOI: 10.1136/ard-2023-223937

Abstract: We read with interest the letter by Braun pertaining to the 2022 update of the ASASEULAR recommendations for the management of axial spondyloarthritis (axSpA). Braun questions whether having nonsteroidal antiinflammatory drugs (NSAIDs) as the first… read more here.

Keywords: 2022 update; axspa; management; treatment ... See more keywords
Photo by mikehindle from unsplash

Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine

Sign Up to like & get
recommendations!
Published in 2023 at "Frontiers in Medicine"

DOI: 10.3389/fmed.2023.1112823

Abstract: Autoimmune bullous diseases (AIBDs) are a heterogeneous group of life-threatening disorders associated with subepidermal or intraepidermal blistering. Skin barrier alterations and prolonged immunosuppressive treatments increase the risk of infections in patients with AIBDs, who are… read more here.

Keywords: 2022 update; autoimmune bullous; bullous diseases; diseases covid ... See more keywords
Photo from wikipedia

Role of B Lymphocytes in the Pathogenesis of NAFLD: A 2022 Update

Sign Up to like & get
recommendations!
Published in 2022 at "International Journal of Molecular Sciences"

DOI: 10.3390/ijms232012376

Abstract: Non-alcoholic fatty liver disease and its related complications are becoming one of the most important health problems globally. The liver functions as both a metabolic and an immune organ. The crosstalk between hepatocytes and intrahepatic… read more here.

Keywords: role lymphocytes; lymphocytes pathogenesis; role; 2022 update ... See more keywords